Will pCR and Pembro Redefine Breast Cancer Treatment?

08:30 EDT 19 Jun 2017 | Medscape

Dr Laura Esserman discusses the ground-breaking I-SPY breast cancer research platform and its most 'exciting' results to date, indicating that pembrolizumab triples pCR in TNBC.
Medscape Oncology

Original Article: Will pCR and Pembro Redefine Breast Cancer Treatment?


More From BioPortfolio on "Will pCR and Pembro Redefine Breast Cancer Treatment?"

Quick Search


Relevant Topics

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...